SI1852433T1 - Derivat karbazola, njegov solvat ali njegova farmacevtsko sprejemljiva sol - Google Patents

Derivat karbazola, njegov solvat ali njegova farmacevtsko sprejemljiva sol

Info

Publication number
SI1852433T1
SI1852433T1 SI200531453T SI200531453T SI1852433T1 SI 1852433 T1 SI1852433 T1 SI 1852433T1 SI 200531453 T SI200531453 T SI 200531453T SI 200531453 T SI200531453 T SI 200531453T SI 1852433 T1 SI1852433 T1 SI 1852433T1
Authority
SI
Slovenia
Prior art keywords
group
pharmaceutically acceptable
carbazole derivatives
solvates
acceptable salts
Prior art date
Application number
SI200531453T
Other languages
English (en)
Slovenian (sl)
Inventor
Masakazu Murata
Yoshihiko Itokazu
Ryu Nakao
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of SI1852433T1 publication Critical patent/SI1852433T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200531453T 2004-10-29 2005-10-28 Derivat karbazola, njegov solvat ali njegova farmacevtsko sprejemljiva sol SI1852433T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004316872 2004-10-29
PCT/JP2005/020250 WO2006046779A1 (ja) 2004-10-29 2005-10-28 カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩
EP05799893A EP1852433B1 (en) 2004-10-29 2005-10-28 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof

Publications (1)

Publication Number Publication Date
SI1852433T1 true SI1852433T1 (sl) 2012-06-29

Family

ID=36227999

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531453T SI1852433T1 (sl) 2004-10-29 2005-10-28 Derivat karbazola, njegov solvat ali njegova farmacevtsko sprejemljiva sol

Country Status (16)

Country Link
US (1) US8329913B2 (US06720351-20040413-C00034.png)
EP (1) EP1852433B1 (US06720351-20040413-C00034.png)
JP (1) JP3997491B2 (US06720351-20040413-C00034.png)
KR (1) KR101223820B1 (US06720351-20040413-C00034.png)
CN (1) CN101048402B (US06720351-20040413-C00034.png)
AT (1) ATE534646T1 (US06720351-20040413-C00034.png)
AU (1) AU2005297800B2 (US06720351-20040413-C00034.png)
CA (1) CA2585642C (US06720351-20040413-C00034.png)
CY (1) CY1112649T1 (US06720351-20040413-C00034.png)
DK (1) DK1852433T3 (US06720351-20040413-C00034.png)
ES (1) ES2378177T3 (US06720351-20040413-C00034.png)
PL (1) PL1852433T3 (US06720351-20040413-C00034.png)
PT (1) PT1852433E (US06720351-20040413-C00034.png)
SI (1) SI1852433T1 (US06720351-20040413-C00034.png)
TW (1) TW200635922A (US06720351-20040413-C00034.png)
WO (1) WO2006046779A1 (US06720351-20040413-C00034.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393181B2 (en) 2004-09-17 2008-07-01 The Penn State Research Foundation Expandable impeller pump
CN101448535B (zh) 2006-03-23 2011-10-19 宾州研究基金会 带有可膨胀叶轮泵的心脏辅助装置
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
JP5489997B2 (ja) 2007-07-19 2014-05-14 シマベイ セラピューティクス， インコーポレーテッド 糖尿病および代謝疾患の治療のためのＲＵＰ３またはＧＰＲｌ１９受容体のアゴニストとしてのＮ−アザ環状置換ピロール、ピラゾール、イミダゾール、トリアゾールおよびテトラゾール誘導体
WO2011003043A1 (en) 2009-07-01 2011-01-06 The Penn State Research Foundation Blood pump with expandable cannula
WO2011041154A1 (en) 2009-10-01 2011-04-07 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
CA2802541A1 (en) 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CN102382037B (zh) * 2010-09-03 2016-01-20 中国医学科学院药物研究所 苯丙酸类化合物及其制法和药物用途
US8485961B2 (en) 2011-01-05 2013-07-16 Thoratec Corporation Impeller housing for percutaneous heart pump
US8597170B2 (en) 2011-01-05 2013-12-03 Thoratec Corporation Catheter pump
US9138518B2 (en) 2011-01-06 2015-09-22 Thoratec Corporation Percutaneous heart pump
WO2012094535A2 (en) 2011-01-06 2012-07-12 Thoratec Corporation Percutaneous heart pump
US9446179B2 (en) 2012-05-14 2016-09-20 Thoratec Corporation Distal bearing support
US9872947B2 (en) 2012-05-14 2018-01-23 Tc1 Llc Sheath system for catheter pump
US8721517B2 (en) 2012-05-14 2014-05-13 Thoratec Corporation Impeller for catheter pump
EP4218887A1 (en) 2012-05-14 2023-08-02 Tc1 Llc Mechanical circulatory support device for stabilizing a patient after cardiogenic shock
US9327067B2 (en) 2012-05-14 2016-05-03 Thoratec Corporation Impeller for catheter pump
US9421311B2 (en) 2012-07-03 2016-08-23 Thoratec Corporation Motor assembly for catheter pump
EP4186557A1 (en) 2012-07-03 2023-05-31 Tc1 Llc Motor assembly for catheter pump
US9358329B2 (en) 2012-07-03 2016-06-07 Thoratec Corporation Catheter pump
US11033728B2 (en) 2013-03-13 2021-06-15 Tc1 Llc Fluid handling system
WO2014164136A1 (en) 2013-03-13 2014-10-09 Thoratec Corporation Fluid handling system
US11077294B2 (en) 2013-03-13 2021-08-03 Tc1 Llc Sheath assembly for catheter pump
US9308302B2 (en) 2013-03-15 2016-04-12 Thoratec Corporation Catheter pump assembly including a stator
US20160030649A1 (en) 2013-03-15 2016-02-04 Thoratec Corporation Catheter pump assembly including a stator
US10583232B2 (en) 2014-04-15 2020-03-10 Tc1 Llc Catheter pump with off-set motor position
EP3131615B1 (en) 2014-04-15 2021-06-09 Tc1 Llc Sensors for catheter pumps
EP3131597B1 (en) 2014-04-15 2020-12-02 Tc1 Llc Catheter pump introducer systems
EP3131599B1 (en) 2014-04-15 2019-02-20 Tc1 Llc Catheter pump with access ports
US10449279B2 (en) 2014-08-18 2019-10-22 Tc1 Llc Guide features for percutaneous catheter pump
US9675739B2 (en) 2015-01-22 2017-06-13 Tc1 Llc Motor assembly with heat exchanger for catheter pump
US9770543B2 (en) 2015-01-22 2017-09-26 Tc1 Llc Reduced rotational mass motor assembly for catheter pump
WO2016118784A1 (en) 2015-01-22 2016-07-28 Thoratec Corporation Attachment mechanisms for motor of catheter pump
US9907890B2 (en) 2015-04-16 2018-03-06 Tc1 Llc Catheter pump with positioning brace
US11491322B2 (en) 2016-07-21 2022-11-08 Tc1 Llc Gas-filled chamber for catheter pump motor assembly
EP3804804A1 (en) 2016-07-21 2021-04-14 Tc1 Llc Fluid seals for catheter pump motor assembly
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN111182904A (zh) 2017-10-06 2020-05-19 吉利德科学公司 包含acc抑制剂的组合治疗
CN116327749A (zh) * 2023-04-21 2023-06-27 重庆医科大学 Gw9662制备治疗非酒精性脂肪性肝炎药物的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166169A (zh) 1994-07-27 1997-11-26 三共株式会社 用作毒蕈碱性受体别构效应物的杂环化合物
YU19299A (sh) 1996-10-30 2000-03-21 ELI LILLY AND COMPANY, Proizvodno i trgovinsko preduzeće organizovano po propisima države Indiana, US Supstituisani tricikli
MY125942A (en) * 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
WO2001026653A1 (fr) 1999-10-15 2001-04-19 Shionogi & Co., Ltd. Inhibiteurs spla2 du type v et/ou du type x
EP1300159B1 (en) 2000-06-29 2007-10-10 Anthera Pharmaceuticals, Inc. Remedies for cancer
WO2002000256A1 (en) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cirrhosis
US20040102442A1 (en) 2000-06-29 2004-05-27 Kohji Hanasaki Remedies for alzheimer's disease
TWI314457B (US06720351-20040413-C00034.png) 2001-03-19 2009-09-11 Shionogi & Co
ATE353876T1 (de) 2001-03-28 2007-03-15 Lilly Co Eli Substituierte carbazole als inhibitoren von spla2
WO2004024939A2 (en) 2002-09-13 2004-03-25 Georgetown University Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
US7268157B2 (en) * 2002-11-26 2007-09-11 Shenzhen Chipscreen Biosciences, Ltd. Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity

Also Published As

Publication number Publication date
AU2005297800B2 (en) 2011-02-03
TWI359148B (US06720351-20040413-C00034.png) 2012-03-01
WO2006046779A1 (ja) 2006-05-04
AU2005297800A1 (en) 2006-05-04
PL1852433T3 (pl) 2012-05-31
ES2378177T3 (es) 2012-04-09
CN101048402B (zh) 2011-11-09
CY1112649T1 (el) 2016-02-10
CN101048402A (zh) 2007-10-03
JP3997491B2 (ja) 2007-10-24
US20100286210A1 (en) 2010-11-11
EP1852433A1 (en) 2007-11-07
KR101223820B1 (ko) 2013-01-17
TW200635922A (en) 2006-10-16
KR20070072554A (ko) 2007-07-04
ATE534646T1 (de) 2011-12-15
CA2585642C (en) 2013-04-02
US8329913B2 (en) 2012-12-11
CA2585642A1 (en) 2006-05-04
JPWO2006046779A1 (ja) 2008-05-22
EP1852433B1 (en) 2011-11-23
PT1852433E (pt) 2012-02-08
EP1852433A4 (en) 2010-07-21
DK1852433T3 (da) 2012-01-30

Similar Documents

Publication Publication Date Title
PL1852433T3 (pl) Pochodne karbazolu, jej solwat lub jej farmaceutycznie dopuszczalna sól
AP804A (en) APO-B-secretion/MTP inhibitory amides.
IL193321A0 (en) Compounds for the treatment of metabolic disorders
EP3091020A3 (en) Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
WO2009123164A1 (ja) 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体
WO2007137008A3 (en) Compounds for the treatment of metabolic disorders
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
WO2007087505A3 (en) Compounds for the treatment of metabolic disorders
UA95613C2 (ru) Соединения для лечения расстройсв метаболизма
CY1111310T1 (el) Ενωσεις για την αγωγη μεταβολικων διαταραχων
CA2630665A1 (en) Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i
WO2009133834A1 (ja) 血管内皮リパーゼ阻害活性を有するケトアミド誘導体
WO2004073611A3 (en) Compounds for the treatment of metabolic disorders
HK1139942A1 (en) Atropisomer of pyrrole derivative
WO2007099162A3 (fr) Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques
JP2007126454A (ja) アニリド誘導体
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
WO2004098496A3 (en) Compounds for the treatment of metabolic disorders
WO2004093806A3 (en) Compounds for the treatment of metabolic disorders
RU2012129932A (ru) Средство для предотвращения или ослабления пигментации
ZA200805740B (en) Novel polyunsaturated compounds, method for preparing same and compositions containing same
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
EP2226321A3 (en) Process for producing thiazolidinediones and intermediates thereof
TW200626143A (en) Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
TW200612912A (en) Benzyloxy derivatives as maob inhibitors